This list is an analysis based on recent market events. It's not an investment recommendation.
About
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
What is Staidson (Beijing) Biopharmaceuticals. stock price today?▼
The current price of 300204.SZ is ¥20.94 CNY — it has decreased by -0.43% in the past 24 hours. Watch Staidson (Beijing) Biopharmaceuticals. stock price performance more closely on the chart.
What is Staidson (Beijing) Biopharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Shenzhen Stock Exchange exchange Staidson (Beijing) Biopharmaceuticals. stocks are traded under the ticker 300204.SZ.
Is Staidson (Beijing) Biopharmaceuticals. stock price growing?▼
300204.SZ stock has fallen by -2.38% compared to the previous week, the month change is a -8.76% fall, over the last year Staidson (Beijing) Biopharmaceuticals. has showed a -48.36% decrease.
What is Staidson (Beijing) Biopharmaceuticals. market cap?▼
Today Staidson (Beijing) Biopharmaceuticals. has the market capitalization of 10B
What is Staidson (Beijing) Biopharmaceuticals. revenue for the last year?▼
Staidson (Beijing) Biopharmaceuticals. revenue for the last year amounts to 216.22M CNY.
What is Staidson (Beijing) Biopharmaceuticals. net income for the last year?▼
300204.SZ net income for the last year is -77.76M CNY.
Does Staidson (Beijing) Biopharmaceuticals. pay dividends?▼
Yes, 300204.SZ dividends are paid annual. The last dividend per share was 0.67 CNY. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Staidson (Beijing) Biopharmaceuticals. have?▼
As of September 05, 2026, the company has 491 employees.
In which sector is Staidson (Beijing) Biopharmaceuticals. located?▼
Staidson (Beijing) Biopharmaceuticals. operates in the Health & Wellness sector.
When did Staidson (Beijing) Biopharmaceuticals. complete a stock split?▼
The last stock split for Staidson (Beijing) Biopharmaceuticals. was on May 05, 2016 with a ratio of 1.3995941:1.
Where is Staidson (Beijing) Biopharmaceuticals. headquartered?▼
Staidson (Beijing) Biopharmaceuticals. is headquartered in Beijing, China.